Back to Search
DILLON WARR, MD
MD
Emergency Medicine Physician
NPI: 1982273082IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
MT222709(PA)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Class of 2021
Research & Publications (20)
The neurokinin1 receptor antagonist aprepitant as an antiemetic for moderately emetogenic chemotherapy.
PMID 16872268·Expert Opin Pharmacother·2006
6-review
Age-related patterns in adaptation to cancer pain: a mixed-method study.
PMID 19594849·Pain Med·2009
4-observational
Challenging roles: insights into issues for men caring for family members with mental illness.
PMID 19477718·Am J Mens Health·2009
8-other
Sources of stress in impoverished neighbourhoods: insights into links between neighbourhood environments and health.
PMID 19236355·Aust N Z J Public Health·2009
8-other
People, places and policies - trying to account for health inequalities in impoverished neighbourhoods.
PMID 19236354·Aust N Z J Public Health·2009
8-other
What patients with cancer want to know about pain: a qualitative study.
PMID 18158232·J Pain Symptom Manage·2008
8-other
A Phase 2 study of perifosine in advanced or metastatic breast cancer.
PMID 17458693·Breast Cancer Res Treat·2008
3-trial
A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
PMID 17397698·J Pain Symptom Manage·2007
3-trial
'Money, stress, jobs': residents' perceptions of health-impairing factors in 'poor' neighbourhoods.
PMID 17291817·Health Place·2007
8-other
Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital.
PMID 16802127·Support Care Cancer·2006
6-review
Evidence-based recommendations for the use of antiemetics in radiotherapy.
PMID 16150504·Radiother Oncol·2005
6-review
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy.
PMID 16104039·Cancer·2005
3-trial
The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
PMID 15939263·Eur J Cancer·2005
1-meta
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
PMID 15837996·J Clin Oncol·2005
3-trial
Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines.
PMID 15592688·Support Care Cancer·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3401 N BROAD ST, JONES HALL 10TH FLOOR
PHILADELPHIA, PA 19140 - Phone
- (215) 707-5435
Quick Facts
- NPI
- 1982273082
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile